Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.
Skip to main content

Zhengming Chen

Kadoorie Biobank Study

Zhengming Chen qualified in medicine at Shanghai Medical University (now Fudan University) in 1983, and gained his DPhil in Epidemiology at the University of Oxford in 1993. He was appointed as Professor of Epidemiology in 2006. He is now the Director of China Program in CTSU, the co-director of China Oxford Centre for International Health Research, and honorary professor of Peking Union Medical College in China.

His main research areas involve large randomized trials of widely practicable treatments for chronic diseases (such as stroke, heart attack and cancer), the environmental and genetic causes of chronic disease as well as efficient strategies for chronic disease control in developing countries. Over the past 20 years, he has been responsible for initiating and organising several large observational epidemiological studies and randomised trials, many of which are based in China and are among the largest in the world (eg, CAST, COMMIT/CCS-2). He is the lead principal investigator in the UK for the China Kadoorie Biobank study of over 0.5 million adults in China, which was established jointly by University of Oxford, Chinese Academy of Medical Sciences and China CDC during 2004-8 to assess the genetic and non-genetic causes of common chronic diseases over the next few decades.